Back to all studies
🎗️
Phase 2
Oncology
in-person
Circulating Tumor DNA
Sponsored by Yale University
Compensation
Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
Duration
3 months
Location
Multi-State
About this study
This is a single-arm, phase II study examining elacestrant in the adjuvant treatment of patients with ER+ breast cancer who test positive for circulating tumor DNA (ctDNA) during the screening period of the trial. Our trial will proceed in three separate phases: screening, treatment, and follow-up.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing er+ breast cancer
- • Able to attend in-person clinic visits
What's included
- • Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Research Study?
Explore clinical trials and paid research opportunities. Compensation varies by study and is never guaranteed.